Showing 1,701 - 1,720 results of 42,905 for search '(( 50 ((a decrease) OR (teer decrease)) ) OR ( e ((mean decrease) OR (point decrease)) ))', query time: 1.05s Refine Results
  1. 1701
  2. 1702
  3. 1703
  4. 1704
  5. 1705

    T0 treatment significantly decreased soluble Aβ oligomers, but not amyloid plaque pathology in APP/E4/Abca1<sup>+/-</sup> mice. by Alexis Y. Carter (3798223)

    Published 2017
    “…N.S., not significant. <b>E,</b> T0 treatment significantly decreases Aβ oligomers in APP/E4/Abca1<sup>+/-</sup> mice. …”
  6. 1706
  7. 1707
  8. 1708
  9. 1709
  10. 1710
  11. 1711
  12. 1712
  13. 1713
  14. 1714
  15. 1715
  16. 1716

    Data_Sheet_1_Botulinum toxin A decreases neural activity in pain-related brain regions in individuals with chronic ocular pain and photophobia.docx by Nicholas Reyes (16390233)

    Published 2023
    “…Four to six weeks after BoNT-A injection, unpleasantness scores decreased (48.1 ± 33.6), but the change was not significant. …”
  17. 1717

    Data_Sheet_2_Botulinum toxin A decreases neural activity in pain-related brain regions in individuals with chronic ocular pain and photophobia.docx by Nicholas Reyes (16390233)

    Published 2023
    “…Four to six weeks after BoNT-A injection, unpleasantness scores decreased (48.1 ± 33.6), but the change was not significant. …”
  18. 1718

    Data_Sheet_1_Botulinum toxin A decreases neural activity in pain-related brain regions in individuals with chronic ocular pain and photophobia.docx by Nicholas Reyes (16390233)

    Published 2023
    “…Four to six weeks after BoNT-A injection, unpleasantness scores decreased (48.1 ± 33.6), but the change was not significant. …”
  19. 1719

    Data_Sheet_2_Botulinum toxin A decreases neural activity in pain-related brain regions in individuals with chronic ocular pain and photophobia.docx by Nicholas Reyes (16390233)

    Published 2023
    “…Four to six weeks after BoNT-A injection, unpleasantness scores decreased (48.1 ± 33.6), but the change was not significant. …”
  20. 1720